New and Special Drug
Ovidrel (rhCG) – Ovulation Induction | HongKong DengYue Medicine
CIMAher (Nimotuzumab) – HNSCC | HongKong DengYue Medicine
Dacogen (Decitabine) – Hematologic Malignancies | HongKong DengYue Medicine
Haiyitan (Glumetinib) – Lung Cancer (NSCLC) | HongKong DengYue Medicine
Junshida (Ongericimab) – Hypercholesterolemia | HongKong DengYue Medicine
Xolair (Omalizumab alfa) – Allergic diseases | HongKong DengYue Medicine
Remicade (Infliximab) – Autoimmune Diseases | HongKong DengYue Medicine
Keruibi (Zamerovimab and Mazorelvimab ) – Rabies PEP | HongKong DengYue Medicine
Beyfortus (Nirsevimab) – Respiratory Syncytial Virus | HongKong DengYue Medicine
JAKAVI (Ruxolitinib) – MF/GVHD | HongKong DengYue Medicine
Inlyta (Axitinib) – RCC | HongKong DengYue Medicine
VUMON (Teniposide) – Antineoplastic Agent | HongKong DengYue Medicine
ILUMETRI (Tildrakizumab) – Tlaque Psoriasis | HongKong DengYue Medicine
KESIMPTA (Ofatumumab) – Multiple Sclerosis | HongKong DengYue Medicine
Aimovig (Erenumab Injection) – Migraine | HongKong DengYue Medicine
Takhzyro lanadelumab-flyo injection – Hereditary Angioedema | HongKong DengYue Medicine
